Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for refractory nocturia in men previously treated with alpha-adrenergic inhibitors
IRCT201208091853N9Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tadalafil in nocturia and benign prostatic hyperplasia (BPH), sponsored by Guilan University of Medical Sciences. Started Aug 2014; status: completed.
02
Drugs
tadalafil
03
Conditions
nocturiabenign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT201208091853N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208091853N9.